We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Integrated Solution for Diabetes Testing Is Efficient

By HospiMedica staff writers
Posted on 28 Aug 2007
Print article
Clinical laboratories will be provided with an integrated system for diabetes testing that automates sample processing, eliminates sample splitting, and improves operating efficiency while reducing costs and errors.

Sysmex America, Inc. (Mundelein, IL, USA) and Bio-Rad Laboratories, Inc. (Hercules, CA, USA) have entered into a non-exclusive, multi-year distribution agreement to jointly market their complementary products with the aim of improving the efficiency and quality of diabetes testing. Sysmex will add Bio-Rad's diabetes testing method to the Sysmex HST-N automation line. Bio-Rad will supply their Variant II turbo link. Sysmex and Bio-Rad will work together to provide seamless service, training, installation, and customer support services.

Bio-Rad's hemoglobin A1c (A1C) blood test measures the amount of glucose attached to the hemoglobin in the red blood cell. This provides an estimate of how well blood glucose levels have been controlled during the previous three to four months. Bio-Rad's test is the industry's gold standard technology for determining whether a patient's diabetes is under control.

We are delighted to continue our long-standing history with Bio-Rad Laboratories, said John Kershaw, president, Sysmex America. The Bio-Rad Variant II turbo link is a perfect complement to the Sysmex HST-N hematology automation line. With the addition of A1c to our automation line, we can truly manage all the testing of the lavender top hematology sample tubes in the laboratory. Sysmex's lavender top management system provides hematology laboratories with the ability to conduct analysis of 90% of tests compatible with EDTA samples, such as complete blood count (CBC), Clostridium difficile, erythrocyte sedimentation rate (ESR), and A1c.

We are pleased to work with Sysmex in offering this integrated testing solution to clinical laboratories as it will enable them to provide superior diabetes testing services to doctors and their patients throughout the United States, said John Goetz, Bio-Rad vice president and group manager of clinical diagnostics.


Related Links:
Sysmex America
Bio-Rad Laboratories
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.